Country: Tanzania
Language: English
Source: Tanzania Medicinces & Medical Devices Authority
Teneligliptin
Cadila Healthcare Limited, INDIA
DPP-4 Inhibitor
Teneligliptin
20
Tablet, Film-coated
Cadila Healthcare Limited, INDIA
Physical description: Light pink coloured, round shaped, biconvex, film coated tablets, plain on both sides; Local technical representative: Abacus Pharma Africa Limited (8473)
Registered/Compliant
2021-06-03
TMDA/DMC/MRE/F/016 Version#1 TANZANIA MEDICINES AND MEDICAL DEVICES AUTHORITY PUBLIC ASSESSMENT REPORT FOR TENGLYN 20 MG (TENELIGLIPTIN HEMIPENTAHYDROBROMIDE HYDRATE EQUIVALENT TO TENELIGLIPTIN 20 MG) FILM COATED TABLETS VERSION NUMBER 1.0 15 APRIL, 2022 P. O. Box 77150, EPI Mabibo, Off Mandela Road, Dar es Salaam, Tanzania Tel: +255-22-2450512/2450751/ 2452108; Fax: +255-22-2450793 Email: info@tmda.go.tz; Website: mwww.tmda.go.tz 1. INTRODUCTION Tenglyn 20mg is a generic medicine of Tenelia 20mg Tablets manufactured by Mitsubishi Tanabe Pharma Corporation & Daiichi Sankyo, Japan. The proposed product is a tablet that contains, as the active ingredient, teneligliptin hemipentahydrobromide hydrate (hereinafter referred to as teneligliptin), a dipeptidyl peptidase (DPP)-4 inhibitor. DPP-4 inhibitors are therapeutic drugs for type 2 diabetes that increase the concentration of active glucagon-like peptide-1 (GLP-1) in the blood, thus promoting glucose-dependent insulin secretion, and inhibiting glucagon secretion, resulting in antihyperglycemic effects. Tenglyn 20mg is approved in Tanzania for use in adult patients. 1.1 PRODUCT DETAILS Registration number TAN 21 HM 0210 Brand name Tenglyn 20mg Generic name, strength, and form Each film coated tablet contains: Teneligliptin Hemipenta Hydrobromide Hydrate equivalent to Teneligliptin 20 mg ATC classification Dipeptidyl peptidase 4 (DPP4) inhibitors (Antidiabetic) ATC code: A10BH Distribution category POM Country of origin India Associated product N/A Marketing Authorization Holder Cadila Healthcare Limited, Zydus Tower, Satellite Cross Roads, Ahmedabad 380 015, India Email: rajeev.nanda@zyduscadila.com Local Technical Representative Abacus Pharma (A) Ltd, 18C, Warehouse No. 4, Nyerere Road, P.O. Box 12294, Dar es salaam, Tanzania Email: rakeshu@kibokogroup.com 1.2 ASSESSMENT PROCEDURE The application for registration of Tenglyn 20mg was submitted on 26 June 2018. The product underwent full assessment. Assessment was completed in 2 (two) rounds of evaluation and the prod Read the complete document